In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $0.49 in the prior trading day, Bluebird bio Inc (NASDAQ: BLUE) closed at $0.51, up 2.28%. In other words, the price has increased by $2.28 from its previous closing price. On the day, 3.93 million shares were traded. BLUE stock price reached its highest trading level at $0.51 during the session, while it also had its lowest trading level at $0.4895.
Ratios:
Our goal is to gain a better understanding of BLUE by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.57 and its Current Ratio is at 0.68. In the meantime, Its Debt-to-Equity ratio is 7.37 whereas as Long-Term Debt/Eq ratio is at 3.67.
Morgan Stanley Upgraded its Underweight to Equal-Weight on December 08, 2023, whereas the target price for the stock was revised from $3 to $7.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 30 ’24 when Klima Thomas J sold 1,006 shares for $0.53 per share. The transaction valued at 529 led to the insider holds 170,000 shares of the business.
Obenshain Andrew sold 34,780 shares of BLUE for $18,270 on Sep 30 ’24. The President and CEO now owns 375,218 shares after completing the transaction at $0.53 per share. On Sep 30 ’24, another insider, Obenshain Andrew, who serves as the Officer of the company, bought 34,780 shares for $0.52 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BLUE now has a Market Capitalization of 98120480 and an Enterprise Value of 349693280. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.79 while its Price-to-Book (P/B) ratio in mrq is 1.85. Its current Enterprise Value per Revenue stands at 6.37 whereas that against EBITDA is -1.158.
Stock Price History:
Over the past 52 weeks, BLUE has reached a high of $5.53, while it has fallen to a 52-week low of $0.45. The 50-Day Moving Average of the stock is -21.07%, while the 200-Day Moving Average is calculated to be -50.20%.
Shares Statistics:
The stock has traded on average 7.62M shares per day over the past 3-months and 7047890 shares per day over the last 10 days, according to various share statistics. A total of 192.77M shares are outstanding, with a floating share count of 192.36M. Insiders hold about 0.80% of the company’s shares, while institutions hold 42.47% stake in the company. Shares short for BLUE as of 1727654400 were 48991273 with a Short Ratio of 6.43, compared to 1724976000 on 49371558. Therefore, it implies a Short% of Shares Outstanding of 48991273 and a Short% of Float of 27.38.
